Free Trial
NASDAQ:BIB

ProShares Ultra Nasdaq Biotechnology (BIB) Price, Holdings, & News

ProShares Ultra Nasdaq Biotechnology logo
$50.32 -1.00 (-1.95%)
As of 03:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)

Key Stats

Today's Range
$50.59
$52.31
50-Day Range
$42.70
$53.03
52-Week Range
$33.78
$69.17
Volume
8,983 shs
Average Volume
9,434 shs
Market Capitalization
$50.82 million
Assets Under Management
$51.84 million
Dividend Yield
1.69%
Net Expense Ratio
0.95%
Aggregate Rating
Moderate Buy

ETF Overview

ProShares Ultra Nasdaq Biotechnology Expenses

TypeBIBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.75%0.56%0.56%0.54%0.53%
Other Expenses0.39%0.47%0.56%0.52%0.56%
Total Expense1.14%0.75%0.76%0.73%0.73%
Fee Waiver-0.19%-0.67%-0.66%-0.50%-0.63%
Net Expense0.95%0.60%0.63%0.63%0.60%
Receive BIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

BIB ETF News Headlines

Turn $1K into $50K with This DeFi Gem
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
ProShares Ultra Nasdaq Biotechn (^BIB-IV)
ProShares Ultra Nasdaq Biotechnology
See More Headlines

BIB ETF - Frequently Asked Questions

ProShares Ultra Nasdaq Biotechnology's stock was trading at $50.66 at the start of the year. Since then, BIB stock has increased by 0.7% and is now trading at $51.00.

ProShares Ultra Nasdaq Biotechnology's top institutional investors include Capital Investment Advisors LLC (0.62%) and Toth Financial Advisory Corp (0.10%).

Shares of BIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ProShares Ultra Nasdaq Biotechnology investors own include Westmoreland Coal (WLB), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Meta Platforms (META), Salesforce (CRM).

Fund Details

Issuer
ProShares
Fund Name
ProShares Ultra Nasdaq Biotechnology
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:BIB
Inception Date
4/6/2010
Fund Manager
Michael Neches, Tarak Dave

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq Biotechnology Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
293

Fund Statistics

Assets Under Management
$51.84 million
Average Daily Volume
$7.15 thousand
Discount/Premium
-0.01%
Leveraged
2.00

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Investor Services Co.
Advisor
ProShare Advisors, LLC
Custodian
JPMorgan Chase Bank, N.A.
Distributor
SEI Investments Distribution Co.
Transfer Agent
J.P. Morgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
10
Put Options
2
Call Options
10
Short Interest
11,700 shs

Miscellaneous

Beta
1.63
Creation Unit
50,000
Creation Fee
$250.00
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Top 10 BIB Holdings

BIB Sector Exposure

BIB Industry Exposure


This page (NASDAQ:BIB) was last updated on 7/31/2025 by MarketBeat.com Staff
From Our Partners